Pharmaceutical Executive Features Vanguard Life Sciences CEO Forum on Pharma ESG

The Vanguard Network is proud to announce that Pharmaceutical Executive highlighted its Life Sciences CEO Forum, held on May 21, 2024, in Boston, in a feature article titled “Seeking Sustainable Solutions: Can Passion and Profit Coexist in Pharma ESG Efforts?”

The article captures a candid discussion among industry leaders on the complex balance between sustainability, public trust, and business realities in life sciences. Forum participants included Amber Edwards, CEO of Sinclair Pharma; Andrew Hall, CEO of Consano Biologics; and Murray Aitken, Senior Vice President at IQVIA.

The conversation focused on how life sciences companies can champion the passion of younger employees while addressing sustainability challenges and entrenched public skepticism. The session reflects Vanguard’s mission of convening leaders for honest dialogue on the most pressing issues facing the sector.

Read the full article at Pharmaceutical Executive.

About The Vanguard Network

The Vanguard Network is a leadership community and advisory platform that helps senior executives sharpen foresight, strengthen performance, and achieve impact. Through forums, exchanges, and programs, Vanguard convenes leaders across industries to share challenges and solutions in a confidential, collaborative setting.